Han Ke
12 Papers
1 Citations
Han Ke is an academic researcher. The author has contributed to research in topics: Biology & Chemistry. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Structural mechanism of SGLT1 inhibitors
TL;DR: In this paper , the authors presented the cryo-EM structure of the hSGLT1-MAP17 hetero-dimeric complex in the presence of the high affinity inhibitor LX2761.
Structural basis of TRPV3 inhibition by an antagonist
Junping Fan,Linghan Hu,Zongwei Yue,Daohong Liao,Fusheng Guo,Han Ke,Daohua Jiang,Yong Yang,Xiaoguang Lei +8 more
TL;DR: Cryogenic electron microscopy structures and G573S mutant structures reveal detailed ligand-binding sites, suggesting that Trpvicin inhibits the TRPV3 channel by stabilizing it in a closed state, and mechanistic insights into the inhibition of TRpV3 by TrPvicin are provided and support TRPv3-related drug development.
25
Diversity-oriented synthesis of cyclohexenes by combining enzymatic intermolecular Diels-Alder reactions and decarboxylative functionalizations
Jin Wang,Han Ke,Jun Yang,Nianxin Guo,Kangdelong Hu,Ruyao Tang,Qiuping Ding,Lei Gao,Xiaoguang Lei +8 more
TL;DR: In this paper , a new chemo-enzymatic strategy for the diversity-oriented syntheses of functionalized cyclohexenes was proposed, which showed a 34-fold increase in catalytic efficiency, broad substrate scope, and good to perfect stereoselectivity.
10
Enzymatic Degradation of Deoxynivalenol with the Engineered Detoxification Enzyme Fhb7
Jun Yang,Kai Liang,Han Ke,Yuebin Zhang,Qian Meng,Lei Gao,Junping Fan,Huancheng Zhou,Junyu Xiao,Xiaoguang Lei +9 more
TL;DR: This work provides a profound mechanistic insight into the enzymatic activities of Fhb7 and paves the way for further utilizing Fhb7-related enzymes in crop breeding and DON detoxification by synthetic biology.
9
Structural Pharmacology of TRPV4 Antagonists.
Junping Fan,Chang Guo,Daohong Liao,Han Ke,Jing Lei,Wenjun Xie,Yuliang Tang,Makoto Tominaga,Zhuo Huang +8 more
TL;DR: Cryo-electron microscopy structures of human TRPV4 are presented in-complex with two potent antagonists, revealing the detailed binding pockets and regulatory mechanisms of TRPV4 gating and provide crucial mechanistic insights into TRPV4 regulation by small-molecule antagonists, which may facilitate future drug discovery targeting TRPV4.
7